Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cytiva MabSelect Sure™ Chromatography Media

Catalog No. 45002988
Click to view available options
Quantity:
25 mL

Protein A affinity medium for capturing MAbs at process scale. Cytiva MabSelect SureTM Chromatography Media is used in the commercial manufacture of monoclonal antibodies.

Has an alkali-tolerant rProteain A ligand designed to enhance protease resistance to produce monoclonal antibodies
  • Withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH
  • Design gives enhanced protease resistance resulting in lower ligand leakage
  • Generic elution profile for different monoclonal antibodies enables platform approach to purification
  • High-flow agarose matrix allows the processing of large feed volumes
  • Used in the commercial manufacture of monoclonal antibodies
TRUSTED_SUSTAINABILITY

Specifications

Quantity 25 mL
For Use With (Application) For Use of Rigorous and Cost-Effective CIP and Sanitization Protocols, Manufacture of Monoclonal Antibodies
Stability Stable in aqueous Buffers commonly used in Protein A Chromatography
Storage Requirements 2°C to 8°C
Binding Capacity 30 mg Human lgG/mL (at 2.4 min. residence time)
Product Type MabSelect SuRe Media
Flow Rate <500 cm/Hoμr
Particle Size 85 μm
Height (English) Bed 7.87 in.
Height (Metric) Bed 20 cm
Includes Certificate of Analysis
Max. Pressure <200 kPa
Matrix Highly Cross-Linked Agarose
pH Range 3 to 12
Storage Buffer 20% Ethanol
Ligand Type Alkali-stabilized Protein A-derived (E. coli)
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.